First County Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
15,088
-411
-3% -$54.2K 0.9% 32
2026
Q1
$2.16M Sell
15,499
-1,854
-11% -$260K 1.15% 18
2025
Q4
$2.13M Sell
17,353
-388
-2% -$47.2K 1.12% 19
2025
Q3
$1.97M Sell
17,741
-1,650
-9% -$188K 1.01% 24
2025
Q2
$2.15M Sell
19,391
-3,373
-15% -$359K 1.16% 21
2025
Q1
$2.55M Sell
22,764
-996
-4% -$103K 1.41% 16
2024
Q4
$2.19M Buy
23,760
+680
+3% +$61.2K 1.23% 19
2024
Q3
$1.94M Sell
23,080
-1,924
-8% -$147K 0.96% 25
2024
Q2
$1.72M Sell
25,004
-1,621
-6% -$108K 0.88% 30
2024
Q1
$1.95M Sell
26,625
-729
-3% -$56.1K 0.95% 28
2023
Q4
$2.22M Sell
27,354
-3,216
-11% -$250K 1.07% 25
2023
Q3
$2.29M Sell
30,570
-4,102
-12% -$316K 1.19% 23
2023
Q2
$2.67M Sell
34,672
-23,563
-40% -$1.88M 1.3% 20
2023
Q1
$4.83M Sell
58,235
-4,502
-7% -$373K 2.37% 4
2022
Q4
$5.39M Buy
+62,737
New +$4.97M 2.58% 4

Other funds holding GILD

First County Bank's GILD Position: Q2 2026 in Review

First County Bank reduced its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, selling an estimated $54.2K and leaving 15,088 shares worth $1.91M. The position accounts for 0.9% of the portfolio, ranked #32.

First County Bank first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.39M in Q4 2022. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First County Bank held 15,088 shares of Gilead Sciences worth $1.91M as of Q2 2026.
  • First County Bank sold 411 Gilead Sciences shares in Q2 2026, an estimated $54.2K.
  • Gilead Sciences made up 0.9% of First County Bank's portfolio in Q2 2026, its #32 holding.
  • First County Bank first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • First County Bank's Gilead Sciences position peaked at $5.39M in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First County Bank's 13F filing for Q2 2026, filed 2 Jul 2026.